CALGARY, Alberta, March 02, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to […]
Myron Holubiak, CEO of Citius Pharmaceuticals took time to update WSA’s listeners on the companies’ progress since their previous interview. Mr. Holubiak provided an overview of the progress on the CTXR’s main products Mino-Lok and Mino-Wrap and shared how they are adapting the product to deal with COVID compliance and restrictions. He also talked about other programs in early stage development and went over key factors that make Citius a unique investment opportunity. Have a look below: […]
SALT LAKE CITY, UT, Feb. 26, 2021 (GLOBE NEWSWIRE) — Today, Mr. Joseph LaStella, President of Green Star Products, Inc. (USOTC: GSPI) stated, “The Company has enough early votes to close the COVID-19 contract with BTR […]
Identified multiple hydrothermal system centers in and surrounding the Project area, representing a possible “cluster” scenario. […]
Completion of research and development phase for HaluGen’s Psychedelics Genetic Test […]
Interview with Timothy Ko, CEO […]
Science in Action confirmed that they have received ethics approval for an in-vivo non-GLP toxicology study of N, N Dimethyltryptamine (DMT). […]
Following the Meeting, Mr. Adrian Smith, Mr. Collin Kim, Mr. Ken Chung, Mr. Kosta Tsoutsis and Mr. Mike Collins will serve on the board of directors. […]
The Company is participating in the BIO CEO and Investor Digital Conference to be held virtually February 16-18, 2021. […]
Vancouver, British Columbia–(Newsfile Corp. – February 4, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTC PINK: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, is […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com